Inventia: IP and medical devices

Inventia is an Australian owned company established in Sydney in 2013. Their key focus is on the development, manufacture and sale of equipment and reagents for advanced medical research assays by means of 3D bioprinting. RASTRUM, is a bench-top medical device that prints 3D cell models, using living human cells, quickly and efficiently within a safe, self-contained environment. Inventia has used a combination of IP rights to protect their business in their commercialisation journey.

Hear about Inventia and their journey to commercialisation and IP protection.

VisionFlex: IP and telehealth

Visionflex is an Australian company that was formed in 2014 that aims to provide high-quality health technology to remote and isolated locations. They have used a combination of IP rights to effectively protect their business.

Hear about VisionFlex and their journey to commercialisation and IP protection.

    Transcript: VisionFlex: IP and telehealth


    About six or seven years ago, we found that there was a need for an improved telehealth service, a device, here in Australia and globally. We created a company from scratch called VisionFlex. VisionFlex has two key products. One is a universal telehealth hub which we've designed, called the ProEX. That is an all-in-one device that allows a very high standard of care for a patient for remote assistance. The second product is a universal handheld camera called the GEIS.

    Transcript: Inventia: International protection


    Our first patent was filed in 2015, and that patent has just been granted in Australia and the U.S. and Europe.


    We decided to cover the biggest market for the applications we made, and that means that whatever we do here we have to ensure that has been done overseas, and the plan for this business is to grow overseas. You have to think about overall in terms of the whole business.


    Transcript: Gecko Traxx: Commercialisation strategies


    It's a super portable way of allowing wheelchair users to access the beach. So currently, to protect ourselves in overseas markets, we have actually filed for a PCT patent application. We've been able to use that time to actually start getting in sales and commercialising it, and then start to understand what markets and what countries are actually going to be useful for us as product.